可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 陈丹,吕安林,苑媛,等. 药物涂层支架研究进展[J]. 心脏杂志, 2006, 18(5):591-594.
[2] 乔志卿,何奔. 药物洗脱支架植入后的支架内再狭窄的研究进展[J]. 心脏杂志, 2008, 20(3):366-369.
[3] Hausleiter J, Kastrati A, Mehilli J, et al. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISARSTEREO trial[J]. Am Heart J, 2003, 146(5):882-886.
[4] 宋杰,吴熹,黄楠,等. 纤维蛋白原与吸附白蛋白、肝素的新型血管支架材料氧化钛的血液相溶性[J]. 生物医学工程学杂志, 2007, 24(5):1097-1101.
[5] Brammer KS, Oh S, Gallagher JO, et al. Enhanced cellular mobility guided by TiO2 nanotube surfaces[J]. Nano Lett, 2008, 8(3):786-793.
[6] Lu J, Rao MP, MacDonald NC, et al. Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features[J]. Acta Biomater, 2008, 4(1):192-201.
[7] Windecker S, Simon R, Lins M, et al. Randomized comparison of a titaniumnitrideoxidecoated stent with a stainless steel stent for coronary revascularization: the TiNOX trial[J]. Circulation, 2005, 111(20):2617-2622.
[8] Karjalainen PP, Ylitalo A, Airaksinen JK. Titanium and nitride oxidecoated stent and paclitaxeleluting stents for coronary revascularization in an unselected population[J]. J Invasive Cardiol, 2006, 18(10):462-468.
[9]Mosseri M, Tamari I, Plich M, et al. Shortand longterm outcomes of the titaniumNO stent registry[J]. Cardiovasc Revasc Med, 2005, 6(1):2-6.
[10]Mosseri M, Miler H, Tamari I, et al. The TitaniumNO stent results of a multicenter registry[J]. EuroInterv, 2006, 2(2):192-196.
[11]张孝忠,张晋,张军,等. 氮氧化钛支架在老年经桡(尺)动脉冠状动脉血运重建中的应用[J]. 第四军医大学学报, 2008, 29(1):封三.
[12]葛海龙,周玉杰,马涵英,等. 雷公藤内酯涂层支架对猪冠状动脉内皮结构和再狭窄的影响[J]. 心脏杂志, 2008, 20(5):525-528.
[13]宋延彬,吕安林,陈丹,等. 雷帕酶素和巴曲酶复合药物涂层支架预防支架内再狭窄的实验研究[J].心脏杂志, 2008, 20(5):525-528.